Mettler-Toledo International (NYSE:MTD) Issues Q4 2025 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) issued an update on its fourth quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 12.680-12.880 for the period, compared to the consensus estimate of 13.120. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Mettler-Toledo International also updated its FY 2025 guidance to 42.050-42.250 EPS.

Analyst Ratings Changes

MTD has been the subject of several research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Evercore ISI upped their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Finally, Bank of America raised their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock traded down $0.93 during mid-day trading on Friday, hitting $1,438.69. 194,321 shares of the stock were exchanged, compared to its average volume of 165,721. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,454.68. The company has a 50-day simple moving average of $1,320.50 and a 200 day simple moving average of $1,235.22. The company has a market capitalization of $29.64 billion, a P/E ratio of 36.43, a P/E/G ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.62 by $0.53. The company had revenue of $1.03 billion during the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the company posted $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Analysts predict that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Activity

In related news, CFO Shawn Vadala sold 300 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,750,875. This represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares of the company’s stock, valued at $368,154.70. This trade represents a 78.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,527 shares of company stock valued at $1,994,981 in the last ninety days. 1.94% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors have recently bought and sold shares of the company. Bank of America Corp DE boosted its position in shares of Mettler-Toledo International by 23.9% in the second quarter. Bank of America Corp DE now owns 81,714 shares of the medical instruments supplier’s stock valued at $95,991,000 after acquiring an additional 15,769 shares during the period. Man Group plc lifted its stake in Mettler-Toledo International by 72.5% in the 2nd quarter. Man Group plc now owns 62,038 shares of the medical instruments supplier’s stock worth $72,877,000 after purchasing an additional 26,073 shares in the last quarter. Holocene Advisors LP lifted its stake in Mettler-Toledo International by 320.2% in the 2nd quarter. Holocene Advisors LP now owns 56,439 shares of the medical instruments supplier’s stock worth $66,300,000 after purchasing an additional 43,007 shares in the last quarter. Sei Investments Co. boosted its holdings in Mettler-Toledo International by 105.4% in the 2nd quarter. Sei Investments Co. now owns 42,402 shares of the medical instruments supplier’s stock valued at $49,806,000 after purchasing an additional 21,763 shares during the period. Finally, AQR Capital Management LLC grew its position in shares of Mettler-Toledo International by 90.6% during the 2nd quarter. AQR Capital Management LLC now owns 41,319 shares of the medical instruments supplier’s stock valued at $48,538,000 after purchasing an additional 19,646 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.